V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004342 | 290003193 | null | 73.8 | Palliative (P) | 2018-04-11 | 2018-04-11 | Carboplatin AUC 2 - 5 | 02 | N | 290021011 | ECX |
| 290004343 | 290003194 | 1.66 | null | Palliative (P) | 2014-08-31 | 2014-09-17 | CISPLATIN + FLUOROURACIL | 02 | N | 290021012 | CARBOPLATIN + CETUXIMAB + FU |
| 290004344 | 290003195 | 1.48 | 45 | Palliative (P) | 2013-10-23 | 2013-11-04 | EOX | 02 | N | 290021014 | AZACITIDINE |
| 290004345 | 290003196 | 1.75 | 61 | Palliative (P) | 2014-12-27 | 2014-12-30 | CAPECITABINE + RT | 02 | N | 290021015 | PLATO TRIAL |
| 290004346 | 290003197 | 1.74 | 74.8 | Palliative (P) | 2015-11-07 | 2015-11-21 | Capecitabine 35days + RT | N | N | 290021017 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 290004347 | 290003198 | 1.88 | 91.05 | Palliative (P) | 2018-01-28 | 2018-02-26 | Capecitabine + Cisplatin | N | N | 290021019 | CAPECITABINE + RT |
| 290004348 | 290003199 | null | 74.1 | Palliative (P) | 2015-10-12 | 2015-11-15 | MCX | N | N | 290021020 | EOX |
| 290004349 | 290003200 | 1.57 | 44.3 | Palliative (P) | 2014-11-19 | 2014-11-30 | Ipilimumab | N | N | 290021021 | CISPLATIN + FLUOROURACIL |
| 290004350 | 290003201 | 1.67 | 74.4 | Adjuvant (A) | 2015-08-07 | 2015-08-12 | Capecitabine 35days + RT | N | N | 290021024 | DOCETAXEL |
| 290004351 | 290003201 | null | 63.6 | Adjuvant (A) | 2015-11-28 | 2015-11-28 | LANREOTIDE | 02 | null | 290021024 | AZACITIDINE |
| 290004352 | 290003201 | 1.57 | null | Palliative (P) | null | 2017-03-21 | null | null | null | 290021024 | CETUXIMAB + RT |
| 290004353 | 290003202 | 1.56 | 71.5 | Palliative (P) | 2013-07-25 | 2013-08-12 | Cisplatin + Etoposide po&iv 3 day | N | N | 290021032 | CAPECITABINE |
| 290004354 | 290003203 | null | null | Neo-adjuvant (N) | null | 2017-12-19 | Capecitabine | null | null | 290021033 | CETUXIMAB |
| 290004355 | 290003204 | 1.72 | 86 | Curative (C) | 2017-08-14 | 2017-08-14 | Capecitabine 35days + RT | null | N | 290021034 | CARBOPLATIN + RT |
| 290004356 | 290003205 | 1.74 | 63.2 | Curative (C) | 2016-10-28 | 2016-11-18 | ECX | null | Y | 290021035 | CAPECITABINE + STREPTOZOCIN |
| 290004357 | 290003205 | null | 78 | Curative (C) | 2017-10-03 | 2017-10-28 | Cisplatin + Docetaxel +Fluorouracil | 02 | Y | 290021035 | TRIAL |
| 290004359 | 290003207 | 1.86 | 91.5 | Palliative (P) | 2013-05-14 | 2013-06-11 | BALLAD Trial | 02 | N | 290021039 | EOX |
| 290004360 | 290006468 | null | 88 | Palliative (P) | 2016-12-22 | 2017-01-11 | PACLITAXEL | 02 | Y | 290021040 | DOCETAXEL |
| 290004361 | 290003208 | 1.87 | 102.5 | null | 2013-05-14 | 2013-06-03 | Carboplatin AUC 6 - 10 | N | N | 290021042 | CAPECITABINE |
| 290004362 | 290003209 | null | 55.6 | Adjuvant (A) | null | 2014-07-21 | Cisplatin +Fluorouracil (3 wk) | null | null | 290021043 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 290004363 | 290003210 | 1.72 | 97.3 | Adjuvant (A) | 2015-10-23 | 2015-10-30 | Trial Unspecified | 01 | Y | 290021044 | GEMCITABINE |
| 290004364 | 290003210 | 1.81 | 49.9 | Adjuvant (A) | 2015-12-23 | 2016-09-04 | BENDAMUSTINE + RITUXIMAB | 2 | N | 290021044 | FLUOROURACIL |
| 290004365 | 290003210 | null | 78.5 | Palliative (P) | 2016-03-15 | 2016-04-03 | FLUOROURACIL + IRINOTECAN | 2 | N | 290021044 | CAPECITABINE + STREPTOZOCIN |
| 290004366 | 290008180 | 1.6 | 0 | Palliative (P) | 2017-03-03 | 2017-03-07 | Trial Unspecified | N | N | 290021050 | CAPECITABINE |
| 290004367 | 290003211 | null | null | Palliative (P) | 2015-01-29 | 2015-02-02 | Capecitabine 42days + RT | 02 | N | 290021051 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004368 | 290003212 | 1.78 | 63.4 | Curative (C) | 2017-12-16 | 2018-01-12 | Ipilimumab | 01 | Y | 290021052 | CARBOPLATIN + RT |
| 290004369 | 290003213 | 1.6 | 51.3 | Curative (C) | 2015-07-20 | 2015-07-30 | Sunitinib 37.5mg continuous | 2 | Y | 290021053 | CISPLATIN + FLUOROURACIL + RT |
| 290004370 | 290003214 | 1.57 | 59.4 | Palliative (P) | 2015-02-22 | 2015-03-20 | FLUOROURACIL + IRINOTECAN | N | N | 290021055 | PEMBROLIZUMAB |
| 290004371 | 290006470 | 1.55 | null | Disease modification (D) | 2016-10-29 | 2016-11-17 | Cisplatin +Fluorouracil (3 wk) | N | N | 290021057 | FCARBOST |
| 290004372 | 290003215 | null | null | Adjuvant (A) | 2014-11-02 | 2014-11-30 | Capecitabine | N | N | 290021060 | FLUOROURACIL |
| 290004373 | 290003216 | 1.7 | 59.8 | Palliative (P) | 2015-03-15 | 2015-04-15 | Capecitabine + Cisplatin | 2 | null | 290021062 | CAPECITABINE + CISPLATIN |
| 290004374 | 290003217 | 1.57 | 59.9 | null | 2017-08-15 | 2017-08-21 | OCTREOTIDE | 02 | null | 290021063 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004375 | 290003217 | null | null | Curative (C) | 2015-02-08 | 2015-02-15 | CHOP - 21 days | 02 | N | 290021063 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004376 | 290003218 | null | 51.1 | Palliative (P) | 2015-10-24 | 2015-11-11 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 290021067 | ECX |
| 290004377 | 290003218 | 1.74 | 67 | Curative (C) | 2016-12-16 | 2016-12-24 | Fluorouracil 96hr infusion+R(4g/m2) | N | N | 290021067 | ECX |
| 290004378 | 290003219 | 0 | 56.6 | Neo-adjuvant (N) | 2013-02-02 | 2013-03-02 | BENDAMUSTINE + RITUXIMAB | N | N | 290021070 | FLUOROURACIL |
| 290004379 | 290003220 | null | 82 | Palliative (P) | 2016-11-28 | 2016-12-08 | EOX | 02 | N | 290021071 | GEMCITABINE |
| 290004380 | 290003221 | null | null | Palliative (P) | null | 2013-03-03 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 290021074 | IRINOTECAN + MDG |
| 290004381 | 290003222 | null | 90.55 | null | 2016-04-13 | 2016-04-23 | CETUXIMAB + CISPLATIN + FU | null | N | 290021076 | PEMBROLIZUMAB |
| 290004382 | 290003223 | 1.69 | 112 | Adjuvant (A) | 2014-09-24 | 2014-10-16 | LANREOTIDE | N | Y | 290021077 | VDC |
| 290004383 | 290003224 | 1.72 | null | null | 2018-01-24 | 2018-01-28 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | 290021079 | CARBOPLATIN + ETOPOSIDE |
| 290004384 | 290003225 | 1.75 | 91 | Palliative (P) | 2014-10-06 | 2015-06-12 | OCTREOTIDE | N | N | 290021080 | CARBOPLATIN + PACLITAXEL |
| 290004385 | 290003226 | null | null | null | null | 2017-08-23 | Cisplatin +Fluorouracil (3 wk) | null | null | 290021087 | CAPECITABINE + RT |
| 290004386 | 290003226 | 1.59 | 65 | Curative (C) | 2016-07-06 | 2016-07-13 | CISPLATIN + VINORELBINE | 2 | Y | 290021087 | EOX |
| 290004387 | 290003227 | 1.63 | 59.1 | Neo-adjuvant (N) | 2013-09-21 | 2013-09-26 | LANREOTIDE | 02 | N | 290021092 | CARBOPLATIN + PACLITAXEL |
| 290004388 | 290003228 | 0 | 80 | Disease modification (D) | 2017-12-02 | 2017-12-23 | OCTREOTIDE | N | N | 290021096 | MITOMYCIN |
| 290004389 | 290003229 | 1.67 | 66.4 | Palliative (P) | 2014-06-25 | 2014-07-08 | OCTREOTIDE | 02 | N | 290021097 | CETUXIMAB |
| 290004390 | 290003229 | 1.81 | 101 | Neo-adjuvant (N) | 2017-07-08 | 2017-07-08 | LANREOTIDE | N | N | 290021097 | DOCETAXEL |
| 290004391 | 290003229 | 1.64 | null | Adjuvant (A) | 2014-01-30 | 2014-01-30 | FLUOROURACIL | 02 | N | 290021097 | CAPECITABINE + RT |
| 290004392 | 290003230 | null | 54.2 | Palliative (P) | 2016-02-03 | 2016-02-03 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290021105 | CAPECITABINE |